Cargando…
Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638476/ https://www.ncbi.nlm.nih.gov/pubmed/34847945 http://dx.doi.org/10.1186/s12943-021-01425-4 |
| _version_ | 1784608953715392512 |
|---|---|
| author | Liu, Aibin Zhu, Jinrong Wu, Geyan Cao, Lixue Tan, Zhanyao Zhang, Shuxia Jiang, Lili Wu, Jueheng Li, Mengfeng Song, Libing Li, Jun |
| author_facet | Liu, Aibin Zhu, Jinrong Wu, Geyan Cao, Lixue Tan, Zhanyao Zhang, Shuxia Jiang, Lili Wu, Jueheng Li, Mengfeng Song, Libing Li, Jun |
| author_sort | Liu, Aibin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8638476 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86384762021-12-03 Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma Liu, Aibin Zhu, Jinrong Wu, Geyan Cao, Lixue Tan, Zhanyao Zhang, Shuxia Jiang, Lili Wu, Jueheng Li, Mengfeng Song, Libing Li, Jun Mol Cancer Correction BioMed Central 2021-12-01 /pmc/articles/PMC8638476/ /pubmed/34847945 http://dx.doi.org/10.1186/s12943-021-01425-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Liu, Aibin Zhu, Jinrong Wu, Geyan Cao, Lixue Tan, Zhanyao Zhang, Shuxia Jiang, Lili Wu, Jueheng Li, Mengfeng Song, Libing Li, Jun Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title | Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title_full | Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title_fullStr | Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title_full_unstemmed | Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title_short | Correction to: Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| title_sort | correction to: antagonizing mir-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638476/ https://www.ncbi.nlm.nih.gov/pubmed/34847945 http://dx.doi.org/10.1186/s12943-021-01425-4 |
| work_keys_str_mv | AT liuaibin correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT zhujinrong correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT wugeyan correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT caolixue correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT tanzhanyao correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT zhangshuxia correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT jianglili correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT wujueheng correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT limengfeng correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT songlibing correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma AT lijun correctiontoantagonizingmir4553pinhibitschemoresistanceandaggressivenessinesophagealsquamouscellcarcinoma |